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Abstract The new aromatic polyketides genoketide A1,
genoketide A2 and prechrysophanol glucuronide are
biosynthetic intermediates of the octaketide chrysophanol.
They were isolated from the alkaliphilic strain
Streptomyces sp. AK 671 together with the new metabolite
chrysophanol glucuronide. The structures of the
compounds were elucidated by mass spectrometry and
NMR methods. Genoketide A2 exhibited a slight and
prechrysophanol glucuronide a more pronounced inhibition
of the proliferation of L5178y lymphoma cells.
Keywords Streptomyces, octaketides, chrysophanol,
fermentation, structure elucidation, antitumor activity
Introduction
Alkaliphilic and alkalitolerant streptomycetes isolated from
various alkaline soils in Durham and Northumberland, UK,
were screened for novel secondary metabolites by HPLC-
diode array analysis (HPLC-DAD). These organisms are
proving to be a rich source of interesting bioactive
compounds, as exemplified by lactonamycin Z and
pyrocoll, secondary metabolites with antibiotic and
antitumor properties [2, 3].
Strain AK 671, which was isolated from a pine wood soil
at Hamsterley Forest, gained our special interest because of
the appearance of a multitude of metabolites in its culture
filtrate. Some of the UV-visible spectra were similar to
aromatic polyketides, but none of them corresponded to the
reference compounds stored in our HPLC-UV-Vis database
[4]. Two new naphthalene diketones, named genoketide A1
(1) and A2 (2), were isolated from the culture filtrate and
their structures determined. The bicyclic diketone 1 was
assumed to be an intermediate in the biosynthesis of the
octaketide chrysophanol in plants and fungi [58], but has
never been isolated because of the fast turnover of polyketo
intermediates and their restricted diffusion from the
polyketide synthase. In this study we describe the discovery
of the postulated precursors genoketide A1 (1) and A2 (2)
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together with prechrysophanol (3) and its glucuronide 4,
which is the first report on the occurrence in nature, and
chrysophanol glucuronide (5) during our HPLC-DAD
screening program. The paper deals with the fermentation,
isolation, structural elucidation and biological activities of
the isolated metabolites. Our investigations on the
biosynthetic pathway of 1 and 2 and its direct aldol addition
product 4 leading to the end-product chrysophanol
glucuronide (5), which was confirmed by feeding
experiments with 1,2-13C-labeled acetate, will be reported
in a forthcoming publication.
Materials and Methods
Producing Organism and Taxonomy
Streptomyces strain AK 671 was isolated from a pine forest
soil collected at Hamsterley Forest, County Durham, UK. It
was examined for genotypic and phenotypic properties
known to be of value in streptomycete systematics [9].
Fermentation and Isolation
Batch fermentations of strain AK 671 were carried out in a
10-liter stirred tank fermentor (Biostat E, B. Braun,
Melsungen, Germany) using a complex medium that
consisted of starch soluble 10 g, glucose 10 g, glycerol 10 g,
Bacto peptone 5.0 g, corn steep powder (Marcor) 2.5 g,
yeast extract (Ohly Kat, Deutsche Hefewerke) 2.0 g, NaCl
1.0 g in 1.0 liter tap water. The fermentor was inoculated
with 5 vol.% of shake cultures, grown in 500-ml
Erlenmeyer flasks of the same medium with one baffle for
48 hours on a rotary shaker at 120 rpm and 27°C. The
fermentation was carried out at 27°C with an aeration rate
of 0.5 vvm and an agitation of 250 rpm. The pH of the
culture was kept constant at pH 8.0 throughout cultivation.
The incubation time depended on the sought metabolites.
Hyphlo Super-cel (2.0%) was added to the fermentation
broth; the broth was separated by multiple sheet filtration
into culture filtrate and mycelium, and the latter was
discarded. The culture filtrate (8.0 liters) was adjusted to
pH 2.0 (1.0 M HCl) and extracted three times with EtOAc
for isolation of 1 and 2. The organic extracts were
combined and concentrated in vacuo to dryness. The crude
product (3.0 g) was dissolved in CH2Cl2 and added to a
diol-modified silica gel column (452.6 cm; LiChroprep
DIOL, 4063 mm; E. Merck), and separation accomplished
by a linear gradient from CH2Cl2 to CH2Cl2 - MeOH (7 : 3)
within 4 hours at a flow rate of 5.0 ml/minute. Fractions
containing the separated compounds 1 and 2 were purified
by Toyopearl HW-40F chromatography (902.5 cm; Tosoh
Biosep) using MeOH as eluent. In order to obtain pure 1
and 2, each fraction was separated by preparative RP-
HPLC (Nucleosil-100 C-18, 10 mm, 25016 mm;
Macherey & Nagel) using 0.5% HCOOH - MeOH as eluent
and a linear gradient from 20 to 60% MeOH over 20
minutes at a flow rate of 24 ml/minute.
For isolation of 3, 4 and 5, the culture filtrate (7.0 liters)
was applied to an Amberlite XAD-16 column (resin
volume 700 ml); the resin was washed with H2O. 4 was
desorbed from the resin with H2O - MeOH (60 : 40), 5 with
H2O - MeOH (40 : 60), and 3 with pure MeOH. 3, 4 and 5
containing eluates were concentrated separately in vacuo to
the aqueous residues and adjusted to pH 2.0 (1.0 M HCl). 3
and 4 were extracted separately twice with n-BuOH, and 5
extracted twice with EtOAc. The extracts were
concentrated to dryness, dissolved in a small volume of
MeOH and purified by Sephadex LH-20 chromatography
(902.5 cm; Amersham) using MeOH as eluent.
HPLC-DAD Analysis
The chromatographic system consisted of an HP 1090M
liquid chromatograph equipped with a diode-array detector
and an HP Kayak XM 600 ChemStation (Agilent
Technologies). Multiple wavelength monitoring was
performed at 210, 230, 260, 280, 310, 360, 435 and
500 nm, and UV-visible spectra measured from 200 to
600 nm. A sample of the fermentation broth was
centrifuged, and the supernatant injected onto an HPLC
column (1254.6 mm) fitted with a guard column
(204.6 mm) filled with 5-mm Nucleosil-100 C-18
(Maisch). The samples were analysed by linear gradient
elution using 0.1% ortho-phosphoric acid as solvent A and
MeCN as solvent B at a flow rate of 2.0 ml/minute. The
gradient was from 0 to 100% for solvent B in 15 minutes
465
Fig. 1 Structures of genoketides A1 (1) and A2 (2), prechrysophanol (3), prechrysophanol glucuronide (4), and
chrysophanol glucuronide (5).
with a 2-minute hold at 100% of solvent B.
Structure Elucidation
UV spectra were measured on a CARY 50 Conc UV-vis
spectrophotometer (Varian) and CD spectra recorded on a
J-715 spectrometer (Jasco). The optical rotation of chiral
compounds was determined on a P-1020 polarimeter
(Jasco) at 589 nm. NMR experiments were carried out on
either an Avance 400 or on a DMX 600 machine (both
Bruker). The NMR pulse programs were taken from the
standard Bruker library. Mass spectral analysis was
achieved on an Agilent 1100 HPLC system in combination
with an Agilent 1100SL ion trap, or, offline, on a time-of-
flight mass detector microTOF (Bruker).
Enzymatic Cleavage of Glucuronic Acid Residues
A catalytic amount of b -glucuronidase (Sigma, 6-8396,
Type VII A (E. coli)) and 1.0 mg of 2 were dissolved in
10 ml H2O. The reaction mixture was stirred at 35°C for 6
hours and extracted with CH2Cl2. The respective aglycon 1
was obtained from the organic layer after removal of the
solvent in vacuo, whereas D-glucuronic acid was isolated
from the aqueous layer.
Biological Activities
An agar plate diffusion assay was used to determine the
antibacterial and antifungal properties of the metabolites
produced by strain AK 671 using Arthrobacter aurescens
DSM 20166, Bacillus subtilis DSM 10, Brevibacillus brevis
DSM 30, Staphylococcus aureus DSM 20231 and
Streptomyces viridochromogenes Tü 57 (Gram-positive
bacteria), Escherichia coli K12, Pseudomonas fluorescens
DSM 50090 and Proteus mirabilis ATCC 35501 (Gram-
negative bacteria). The yeasts and filamentous fungi
examined were Candida albicans Tü 164, Saccharomyces
cerevisiae ATCC 9080, Botrytis cinerea Tü 157 and
Penicillium notatum Tü 136. Ten m l of the samples were
applied to filter paper disks (6 mm diameter), which were
added to inoculated test plates that were incubated for 24
hours (bacteria) and 48 hours (fungi) at temperatures that
ensured the optimal growth of the test organisms.
Murine leukemic lymphoblasts cells L5178y (ATCC
CRL 1722) were used [10, 11] to establish the inhibition of
tumor cell proliferation. The tumor cells were grown as
described previously [12], but with the enrichment of the
RPMI-1640 medium with 10% fetal calf serum. All of the
cells were kept in a humidified atmosphere of 5.0% CO2
and 95% air. Cell viability was assessed by using 
the methylthiazolyldiphenyl-tetrazolium bromide (MTT)
method as previously described [13]. The cells were used to
seed 96-well plates at a density of 10103 cells per well
with or without the compound. After 72 hours, the plates
were analysed on a microplate reader (model 450; Bio-Rad)
at a test wavelength of 595 nm. Ten parallel assays were
performed for each concentration of the respective
compounds. The ED50 concentrations were determined by
logit regression [14].
Results
Taxonomy of the Producing Strain
The presence of LL-diaminopimelic acid in whole-organism
hydrolysates [15] together with colonial and morphological
properties [16] indicated that strain AK 671 is a member of
the genus Streptomyces. The strain produces straight chains
of smooth surfaced spores. When the almost complete 16S
rRNA gene sequence of the isolate was compared with
corresponding sequences of representatives of the genus
Streptomyces it was found to form a distinct phyletic line in
the Streptomyces 16S rRNA gene tree. It was most closely,
albeit only loosely, associated with the type strain of
Streptomyces auvicolor (98.6% 16S rRNA gene similarity).
It is evident from these results that isolate AK 671 has
properties consistent with it being assigned to a new
Streptomyces species.
Screening, Fermentation and Isolation
Samples of culture filtrates from shake cultures of
Streptomyces strain AK 671 were screened by using our
HPLC-DAD method. Several major peaks were monitored
in the HPLC chromatogram, and were found to be strongly
dependent on the cultivation time of strain AK 671.
Compounds 1 and 2 with retention times of 7.9 and 5.9
minutes, respectively, were the dominant metabolites at an
early stage of fermentation (Fig. 2a), whereas compounds 
4 (retention time 5.5 minutes) and 5 (retention time 
7.2 minutes) were accumulated during the ongoing
fermentation process (Fig. 2b). The lack of UV-visible
spectral identity among the 867 reference compounds
stored in our HPLC-UV-Vis database prompted us to
undertake more detailed investigations on the production
behaviour of the strain. Some of the produced metabolites
were detected solely in the culture filtrate or in EtOAc
extracts when acidifying the culture filtrate to pH 2.0,
thereby indicating the precence of strong acidic lipophilic
compounds (2, 4 and 5).
Strain AK 671 showed alkaliphilic growth properties
resulting in a 20% increased biomass production when the
pH was kept constant at 8.0 during fermentation compared
to growth at pH 7.0. Batch fermentations were carried out
in a 10-liter fermentor using a complex medium; the pH of
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the culture was kept constant at pH 8.0. The production of
the aglycon genoketide A1 (1) started at 19 hours after
inoculation and reached a concentration of 390 mg/liter at
43 hours. The conversion from 1 into the glucuronated
genoketide A2 (2) occurred between 24 and 64 hours of
incubation and reached a maximal concentration of
600 mg/liter after 64 hours. In the course of the
fermentation process, 2 was completely converted to
prechrysophanol glucuronide (4) after 76 hours of
incubation reaching a concentration of 600 mg/liter of 4,
followed by the conversion of 4 into chrysophanol
glucuronide (5) between 76 and 236 hours of fermentation.
5 reached a final amount of 355 mg/liter, whereas the
aglycon prechrysophanol (3) resulted in a maximal amount
of 63 mg/liter after a fermentation time of 144 hours. The
course of the conversion of genoketide intermediates 
via prechrysophanol glucuronide to the end-product
chrysophanol glucuronide (5) is shown in Fig. 3.
For isolation of the precursors 1 and 2, the fermentation
was terminated after incubation for 42 hours, and the
metabolites isolated from the culture filtrate by extraction
with EtOAc and purified by subsequent chromatography on
diol-modified silica gel, Toyopearl HW-40F and preparative
reversed-phase HPLC. 1 and 2 were obtained as beige
powders after lyophilisation. The fermentation was
extended to an incubation time of about 160 hours for the
isolation of 3, 4 and 5. The metabolites were isolated from
the culture filtrate by Amberlite XAD-16 chromatography
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Fig. 2 HPLC analysis of a culture filtrate of Streptomyces sp. AK 671 at (a) fermentation time of 48 hours, and (b)
fermentation time of 135 hours, monitored at 230 nm, and UV-visible spectra of genoketides A1 (1; 7.9 minutes) and A2 (2;
5.9 minutes), of prechrysophanol glucuronide (4; 5.5 minutes), chrysophanol glucuronide (5; 7.2 minutes), and juglomycin F
(7; 7.05 minutes).
and purified by extraction and Sephadex LH-20
chromatography. Compounds 3, 4 and 5 were obtained as
yellow powders after lyophilisation.
Structure Elucidation
Genoketide A2 (2) showed a molecular weight of 434
Dalton ([MH] m/z 435) in its ESI mass spectrum. In the
EI and DCI mass spectral analysis only a fragment with m/z
240 was detectable. The molecular formular C15H12O3 of
this partial structure was deduced by high-resolution 
mass spectrometry. 1H-NMR investigations indicated the
presence of a glucuronide, three neighbouring and one
isolated aromatic proton, and a methylene and two methyl
groups. In the 13C-NMR spectrum the signals for the sugar
moiety, ten aromatic carbons, two carbonyl functions, two
methyl groups and one methylene unit were visible (Table
1).
The structure of the naphthalene portion and the
constitution of the glucuronic acid moiety was established
in a series of HMBC experiments (Fig. 4a). The positions
of the substituents of the naphthalene core were evident
from interactions of CH3-10 with C-2, of CH2-11 with C-2,
C-3, and C-4, of the anomeric proton H-1 with C-8, and of
the free hydroxy group with C-1. This constitution was
validated by ROESY interactions (Fig. 4b). Furthermore,
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Fig. 3 Time course of the conversion of the intermediates genoketides A1 (1; ) and A2 (2; ) and of prechrysophanol
glucuronide (4; ) to the end-product chrysophanol glucuronide (5; ) during fermentation.
Table 1 NMR data of 2 in Me2CO-d6 (
1H: 600 MHz; 13C:
150 MHz)




4 122.1 7.18 s
4a 137.4 —
5 124.0 7.50 d (7.9)
6 128.5 7.44 dd (7.7, 7.9)




10 32.0 2.54 s
11 48.4 3.93 d (2.4)
12 205.4
13 29.9 2.14 s
1 103.9 5.40 d (7.5)
2 74.2 3.77 dd (8.1, 8.6)
3 76.9 3.71 dd (8.7, 8.8)
4 72.5 3.82 t (9.2)
5 76.3 4.25 d (9.5)
6 169.9 —
the relative configuration of all of the stereogenic centers of
the sugar part was deducible from the ROESY experiment.
The chemical shift of 1-H (5.40 ppm) and its coupling
constant with 2-H (J7.5 Hz) showed the anomeric center
to be b -configured. Enzymatic hydrolysis using a b -
glucuronidase gave free glucuronic acid, which was
assigned to be the D-enantiomer by its optical rotation. The
aglycon of genoketide A2 (2) was found to be fully
identical with genoketide A1 (1) in HPLC coelution
experiments. The spectroscopic and physical data of 1 was
in full agreement with the published data of the synthetic
analog [7].
The molecular formula C21H22O10 of prechrysophanol
glucuronide (4) was established by high-resolution ESI
mass spectroscopy ([MH] m/z 433.1159). In the 1H-
NMR spectrum of 4 an ABC spin system of three aromatic
protons and the signals of an isolated aromatic proton was
found, and, in addition, two diastereotopic aliphatic
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Fig. 4 Important HMBC (A, ) and ROESY (B, ) interactions used for the structural elucidation of genoketide A2 (2).
Table 2 NMR data of 4 and 5 in MeOH-d4 (
1H: 400 MHz; 13C: 100 MHz)
4 5
No.
d (13C) [ppm] d (1H) [ppm] (J in Hz) d (13C) [ppm] d (1H) [ppm] (J in Hz)
1 205.9 — 163.9 —
2 52.9 2.81 d (15.9) 125.5 7.12 s
2.88 d (16.1)
3 71.4 — 149.7 —
4 44.2 3.14 d (17.2) 121.1 7.56 s
3.07 d (17.2)
4a 138.3 — 134.1 —
5 123.5 7.40 d (7.6) 123.3 8.00 d (7.7)
6 132.2 7.51 t (8.0) 137.1 7.80 dd (7.7, 8.3)
7 113.7 7.23 d (7.8) 125.2 7.73 d (8.3)
8 158.6 — 159.7 —
8a 116.8 — 123.3 —
9 165.1 — 189.9 —
9a 112.8 — 115.5 —
10 119.5 7.11 s 183.8 —
10a 141.6 136.8 —
1 104.7 5.02 d (7.6) 103.5 5.18 d (7.6)
2 75.1 3.72 dd (7.9, 9.1) 74.7 3.75 dd (7.6, 9.1)
3 77.0 3.56 t (9.1) 77.2 3.58 dd (8.9, 9.1)
4 73.1 3.70 t (9.9) 73.1 3.69 dd (8.9, 9.7)
5 77.1 4.03 d (9.7) 76.9 4.05 d (9.7)
6 172.5 — 172.9 —
Me-3 22.1 1.40 s 22.2 2.44 s
methylene units, one aliphatic methyl group and the same
sugar moiety as in genoketide A2 (2). In the 13C-NMR
spectrum an additional keto group, two hetero-atom
substituted sp2, four quarternary carbon atoms, and an
aliphatic tertiary alcohol were detected (Table 2).
The presence of the two methylene units and the tertiary
alcohol function attached to a presumably identical
naphthalene moiety bearing a glucuronic acid residue as in
2 was indicative of a cyclization of genoketide A2 (2) to
give a third ring system annelated to the naphthalene core.
This assumption was unambiguously confirmed by 
HMBC-, COSY-, and NOESY interactions as depicted in
Fig. 5.
Compound 4 was thus identified as the new 8-O-
glucuronidated derivative of the known natural product
prechrysophanol [8]. As for genoketide A2 (2), the D-
glucuronic acid residue was stereochemically characterized
after its enzymatic cleavage by analysis of its optical
rotation. The aglycon of 4, prechrysophanol, was
completely identical with the likewise isolated—albeit in
very low quantities—secondary metabolite 3 (Fig. 6). The
stereogenic center at C-3 was shown to be R-configured by
comparison of the optical rotation of 3 as isolated from AK
671 ([a ]D2043°), with the data published for (R)-
prechrysophanol from Aloe graminicola ([a]D2045°) [8].
The molecular formula C21H18O10 of compound 5 was
deduced from high-resolution ESI mass spectroscopy
([M2HNa] m/z 451.0640). The characteristic UV
spectrum of 5 (see Fig. 2) indicated the presence of an
anthraquinone moiety. In the 1H-NMR the signals of an
aromatic ABC spin system and of a glucuronic acid residue
were once again observed (see Table 2). Furthermore, two
isolated aromatic protons and a methyl group attached to a
sp2-carbon atom were detected. In the 13C-NMR spectrum
of 5 two keto groups, two heteroatom-substituted sp2
carbons and five quarternary sp2 carbons were visible.
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Fig. 5 Full set of HMBC ( ), COSY ( ), and ROESY ( ) interactions used for the structural elucidation of compound
4.
Fig. 6 Elucidation of the absolute configuration of 4 by enzymatic cleavage to give D-glucuronic acid and (R)-
prechrysophanol (3), which also occurs as a minor metabolite in strain AK 671.
These findings, together with the mass difference of four
atomic units as compared to 4, suggested that compound 5
was the new natural product chrysophanol glucuronide.
This structural proposal was fully confirmed by HMBC
experiments (Fig. 7), in particular those based on the
interactions of H-5 with C-8a, C-10 and C-10a, of H-6 with
C-8a and C-10a, of H-7 with C-8 and C-8a, of the anomeric
proton H-1 with C-8, of H-2 with C-9a, and of H-4 with
C-9a and C-10 (Fig. 3). The absolute configuration of the
D-glucuronic acid substituent was again established after its
enzymatic cleavage. The identity of the aglycon of 5,
chrysophanol, was further checked by coelution with an
authentic reference sample. Remarkably, strain AK 671 did
not produce any detectable amounts of chrysophanol.
The physico-chemical properties of compounds 2, 4, and
5 are summarized in Table 3.
Biological Activity
Compounds 15 did not show antibacterial or antifungal
activities against any of the tested organisms up to a
concentration of 1.0 mg/ml. When the effects of
genoketides on the viability (cell growth) of L5178y tumor
cells were examined, it was established that the cells were
inhibited by prechrysophanol glucuronide (4) with an ED50
value of 6.30.7 mg/ml. None of the other compounds
reached the sensitivity level of an ED50 below 10 mg/ml. An
exposure of 10 mg/ml of genoketide A2 (2) to these cells
resulted in a 15.1% reduction of cell growth, while the
reduction determined for chrysophanol glucuronide (5) and
juglomycin F (7) were 12.8% and 6.7%, respectively.
Discussion
Intermediates in the biosynthetic pathway of aromatic
polyketides are usually postulated as they are difficult to
detect or isolate because of their high chemical reactivity
and fast turnover into the end products. Exceptions are
found in genetically engineered microorganisms, especially
streptomycetes, which are blocked in distinct biosynthetic
enzymes of the aromatic polyketides leading to a variety of
shunt products, which have been summarized in a review
article by David Hopwood [17]. However, wild-type strain
Streptomyces AK 671 accumulated three intermediates in
high amounts in the culture filtrate which were
continuously transformed from one to another leading to
the end product chrysophanol glucuronide (5). The
intermediate 1 had previously been postulated in the
biosynthesis of chrysophanol in plants and fungi [5, 7] but
had not been detected or isolated from an organism. We
designated genoketide A1 (1) as the ‘Harris-Franck
diketone’ in honour of the outstanding synthetic and
biosynthetic contributions of Thomas M. Harris and
Burchard Franck on the role of this compound. The
conversion of genoketide A1 (1) to prechrysophanol (3)
seems to be a side-pathway of strain AK 671, resulting in
relative small amounts of 3 during the fermentation
process, and it is strongly dependent on the cultivation
conditions. We could not find the postulated end-product of
3, which would be expected to be chrysophanol, even after
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Fig. 7 Important HMBC correlations used for the
structural elucidation of 5.
Table 3 Physico-chemical properties of compounds 2, 4, and 5
2 4 5
Appearance Red powder Orange solid Yellow solid
Molecular weight 434 434 430
Molecular formula C21H22O10 C21H22O10 C21H18O10
HRMS (m/z) EI() ESI() ESI()
Found 240.0786 [Msugar] 433.1159 [MH] 451.0640 [M2HNa]
Calcd. 240.0789 [Msugar] 433.1140 [MH] 451.0641 [M2HNa]
UV (MeOH) lmax [nm] 226, 301, 346 221, 267, 292, 302, 395 221, 258, 412
[a ]D20 (MeOH) [°] 14.5 (c0.106) 47.2 (c0.04) 19.3 (c0.04)
Mp (MeOH) [°C] 190 158 164
changing cultivation media and fermentation conditions.
These findings are in contrast to those in plants, where
prechrysophanol (3) was identified as one of the
intermediates in the biosynthesis of anthraquinones in Aloe
graminicola [18]. The cyclization and aromatization of the
glucuronidated derivatives 2 and 4 to finally yield 5, by
contrast, seems to be the dominant biosynthetic pathway in
AK 671, thereby suggesting an activating effect of the
glucuronic acid moiety in the respective biosynthetic
transformations.
Streptomyces strain AK 671 does not only produce
genoketides A1 (1) and A2 (2), prechrysophanol (3)
together with its glucuronide 4 and chrysophanol
glucuronide (5), but in addition—depending on the
cultivation conditions above all the cultivation medium—
several other aromatic polyketides. These include the
hexaketide BSM1 (6), which was described as a shunt
product from the genetically engineered Streptomyces
lividans K4-114 [19], the heptaketide juglomycin F (7),
which was isolated from a wild-type Streptomyces strain
[20], DMAC (8), a member of the rarely occurring a -
methyl anthraquinones [21], and the octaketides
bhimamycins A (9) and B (10) [22]. The structures of these
literature-known polyketide metabolites are summarized in
Fig. 8.
The fermentation, isolation and structural elucidation of
further metabolites produced by Streptomyces strain AK
671 that presumably belong to the family of aromatic
polyketides given by their UV-visible characteristics are
still under investigation and will be reported in forthcoming
publications. They will give an insight into the complex
flow of precursors of the biosynthetic pathway of aromatic
polyketides in this highly creative streptomycete strain,
which reacts dramatically to changes in fermentation
conditions resulting in an altered pattern of secondary
metabolites.
References
1. Paululat T, Katsifas EA, Karagouni AD, Fiedler H-P.
Grecoketides A and B, new naphthoquinones from
Streptomyces sp. Acta 1362. Europ J Org Chem, in press
(2008)
2. Dieter A, Hamm H, Fiedler H-P, Goodfellow M, Müller
WEG, Brun R, Beil W, Bringmann G. Pyrocoll, an
antibiotic, antiparasitic and antitumor compound produced
by a novel alkaliphilic Streptomyces strain. J Antibiot 56:
639–646 (2003)
3. Höltzel A, Dieter A, Schmid DG, Brown R, Goodfellow M,
Beil W, Jung G, Fiedler H-P. Lactonamycin Z, an antibiotic
and antitumor compound produced by Streptomyces
sanglieri strain AK 623. J Antibiot 56: 1058–1061 (2003)
4. Fiedler H-P. Biosynthetic capacities of actinomycetes. 1.
Screening for novel secondary metabolites by HPLC and
UV-visible absorbance libraries. Nat Prod Lett 2: 119–128
(1993)
5. Harris TM, Webb AD, Harris CM, Wittek PJ, Murray TP.
Biogenetic-type syntheses of emodin and chrysophanol. J
Am Chem Soc 98: 6065–6067 (1976)
6. Webb AD, Harris TM. A biogenetically modeled synthesis
of eleutherin. Tetrahedron Lett 18: 2069–2072 (1977)
7. Franck B, Stange A. Pilzinhaltstoffe, 32. Nachweis einer
bicylischen Zwischenstufe der Anthrachinon-Biosynthese.
Liebigs Ann Chem 1981: 2106–2116 (1981)
8. Yenesew A, Ogur JA, Duddeckt H. (R)-Prechrysophanol
from Aloe graminicola. Phytochemistry 34: 1442–1444
(1993)
9. Xu C, Wang L, Cui Q, Huang Y, Liu Z, Zheng G,
Goodfellow M. Neutrotolerant acidophilic Streptomyces
species isolated from acidic soils in China: Streptomyces
guandensis sp. nov., Streptomyces paucisporeus sp. nov.,
Streptomyces rubidus sp. nov. and Streptomyces yanglinensis
sp. nov. Int J Syst Evol Microbiol 56: 1109–1115 (2006)
10. Müller WEG, Maidhof A, Zahn RK, Schröder HC, Gasic
MJ, Heidemann D, Bernd A, Kurelec B, Eich E, Seibert G.
Potent antileukemic activity of the novel cytostatic agent
472
Fig. 8 Structures of 2-methyl-4-oxo-4H-chromen-5-yl-acetic acid (BSM1) (6), juglomycin F (7), 3,8-dihydroxy-1-
methylanthraquinone-2-carboxylic acid (DMAC) (8) and bhimamycin A (9) and B (10) produced by Streptomyces sp. AK 671.
avarone and its analogues in vitro and in vivo. Cancer Res
45: 4822–4827 (1985)
11. Müller WEG, Zahn RK, Gasic MJ, Dogovic N, Maidhof A,
Becker C, Diehl-Seifert B, Eich E. Avarol, a cytostatically
active compound from the marine sponge Dysidea avara.
Comp Biochem Physiol 80C: 47–52 (1985)
12. Müller WEG, Maidhof A, Zahn RK, Shannon WM. Effect
of 9-b-D-arabinofuranosyladenine on DNA synthesis in vivo.
Cancer Res 37: 2282–2290 (1977)
13. Taglialatela G, Robinson R, Perez-Polo JR. Inhibition of
nuclear factor kappa B (NFkB) activity induces nerve
growth factor-resistant apoptosis in PC12 cells. J Neurosci
Res 47: 155–162 (1997)
14. Sachs L. Angewandte Statistik. Springer, Berlin (1974)
15. Staneck JL, Roberts GD. Simplified approach to the
identification of aerobic actinomycetes by thin-layer
chromatography. Appl Microbiol 28: 226–231 (1974)
16. Williams ST, Goodfellow M, Alderson G. Genus
Streptomyces Waksman and Henrici 1943, 339AL. In
Bergey’s Manual of Systematic Bacteriology, Vol. 4. Ed.
Williams ST, et al., pp. 2452–2492, Williams & Wilkins,
Baltimore (1989)
17. Hopwood DA. Genetic contributions to understanding
polyketide synthases. Chem Rev 97: 2465–2497 (1997)
18. Yenesew A, Ogur JA, Duddeck H. (R)-Prechrysophanol
from Aloe graminicola. Phytochem 34: 1442–1444 (1993)
19. Kalaitzis JA, Moore BS. Heterologous biosynthesis of
truncated hexaketides derived from the actinorhodin
polyketide synthase. J Nat Prod 67: 1419–1422 (2004)
20. Lessmann H, Krupa J, Lackner H, Jones PG. Neue
Juglomycine. Z Naturforsch 44b: 353–363 (1989)
21. Krupa J, Lessmann H, Lackner H. Ein a -
Methylanthrachinon aus Streptomyceten. Liebigs Ann Chem
1989: 699–701 (1989)
22. Fotso S, Maskey RP, Grün-Wollny I, Schulz K-P, Munk M,
Laatsch H. Bhimamycin AE and bhimanone: isolation,
structure elucidation and biological activity of novel quinone
antibiotics from a terrestrial streptomycete. J Antibiot 56:
931–941 (2003)
473
